Corix Bioscience, Inc. (CXBS) SEC Filing 8-K Material Event for the period ending Tuesday, October 16, 2018

Corix Bioscience, Inc.

CIK: 1433821 Ticker: CXBS

View differences made from one to another to evaluate Corix Bioscience, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Corix Bioscience, Inc..


Assess how Corix Bioscience, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Corix Bioscience, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Corix Bioscience, Inc. provided additional information to their SEC Filing as exhibits

Ticker: CXBS
CIK: 1433821
Form Type: 8-K Corporate News
Accession Number: 0001659173-18-000304
Submitted to the SEC: Tue Oct 23 2018 7:34:44 PM EST
Accepted by the SEC: Wed Oct 24 2018
Period: Tuesday, October 16, 2018
Industry: Operators Of Nonresidential Buildings
  1. Ending Agreement
  2. Financial Exhibit

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: